Comments on: Omeros discontinues renal disease phase 3 treatment post interim review failure https://lifescivoice.com/omeros-discontinues-renal-disease-phase-3-treatment-post-interim-review-failure/ Life Sciences Voice | The leading resource for life sciences industry executives. Wed, 18 Oct 2023 01:24:40 +0000 hourly 1 https://wordpress.org/?v=6.8.1